The Cambridge, U.K.–based company said yesterday that it will use the money to boost the global commercialization of its Versius surgical robotic system, making keyhole surgery accessible to more people worldwide. Business Weekly notes that the newest money raise means that CMR Surgical has brought in nearly $1 billion in recent years.
CMR has already launched Versius in Europe, Australia, India and the Middle East. Company officials tout the Versius system’s size, portability and versatility.
“This latest financing equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide, whilst providing full flexibility to achieve our goals. This major injection of capital that now values us at $3billion not only reflects the level of interest we have seen in our product, but also the scale of the business, and will enable significant technology developments and global expansion,” CMR Surgical CEO Per Vegard Nerseth said in a news release.
The Series D round also included new international investors RPMI Railpen, Tencent and Chimera, and existing investors LGT and its affiliate impact investing platform Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare.